|
Press Releases |
|
|
|
Friday, May 13, 2022 |
|
祝賀!國際頂級醫學期刊《自然-醫學》同時發表兩篇關於華領醫藥全球首創糖尿病新藥多格列艾汀的III期研究結果的同行評議論文 |
華領醫藥(“公司”,香港聯交所主機板股份代號:2552.HK)今日宣佈,國際頂級醫學刊物《自然-醫學》(Nature Medicine)雜誌同時線上發表了兩篇公司全球首創糖尿病新藥葡萄糖激酶啟動劑(GKA)多格列艾汀(dorzagliatin)的III期註冊臨床研究結果的同行評議論文。 more info >> |
|
Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine |
Hua Medicine (the "Company", stock code on the main board of the Hong Kong Stock Exchange: 2552.HK) today announces that, two peer-reviewed papers on the Phase III clinical trial results of dorzagliatin more info >> |
|
Thursday, March 17, 2022 |
|
华领医药公布2021年全年业绩 |
华领医药(「公司」,香港联交所股份代号:2552),今天宣布公司及其附属公司截至2021年12月31日止,经审核的全年业绩(「报告期」)。 more info >> |
|
華領醫藥公佈2021年全年業績 |
華領醫藥(「公司」,香港聯交所股份代號:2552),今天宣佈公司及其附屬公司截至2021年12月31日止,經審核的全年業績(「報告期」)。 more info >> |
|
Hua Medicine Announces 2021 Annual Results |
Hua Medicine (the "Company", Stock Code: 2552.HK) today announces the audited annual results of the Company and its subsidiaries for the year ended December 31, 2021 (the "Reporting Period"). The Reporting Period witnessed significant milestones in the commercialization process of dorzagliatin. more info >> |
|
Friday, November 13, 2020 |
|
陈力博士受邀参加浦东开放30周年庆祝大会 |
11月12日,浦东开发30周年庆祝大会在上海世博中心举行。中共中央总书记、国家主席、中央军委主席习近平出席大会并发表重要讲话。华领医药创始人、CEO陈力博士受邀参加了庆祝大会,与习近平总书记进行了大会合影留念。 more info >> |
|
陳力博士受邀參加浦東開放30周年慶祝大會 |
11月12日,浦東開發30周年慶祝大會在上海世博中心舉行。中共中央總書記、國家主席、中央軍委主席習近平出席大會並發表重要講話。華領醫藥創始人、CEO陳力博士受邀參加了慶祝大會,與習近平總書記進行了大會合影留念。 more info >> |
|
Wednesday, October 14, 2020 |
|
华领医药宣布获得《药品生产许可证》 |
华领医药(「公司」,香港联交所主板股份代号:2552.HK)宣布,经过药品上市许可持有人(MAH) 体系审核和现场核查后,公司已获得由上海市药品监督管理局颁发的在研全球首创新药多扎格列艾汀(dorzagliatin)《药品生产许可证》。 more info >> |
|
Sunday, September 26, 2021 |
|
Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin |
Hua Medicine (2552.HK) announced that at the 6th China BioMed Innovation & Investment Conference (CBIIC), Professor Jianhua MA, Director, Department of Endocrinology, Nanjing First Hospital, Standing Member of the Chinese Diabetes Society, as one of the principal researchers presented the results from a clinical study called DREAM, which showed that dorzagliatin, a glucokinase activator and a first-in-class investigational drug of Hua Medicine, may make progress in diabetes remission. more info >> |
|
研究者公佈有關多格列艾汀糖尿病緩解的重要研究 |
more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
特步宣布战略性出售K-Swiss及帕拉丁 并优化财务结构
May 9, 2024 20:28 HKT/SGT
|
|
|
特步宣佈戰略性出售K-Swiss及帕拉丁 並優化財務結構
May 9, 2024 20:25 HKT/SGT
|
|
|
Xtep Announces Strategic Divestiture of K-Swiss and Palladium and Enhanced Financial Structure
May 9, 2024 20:18 HKT/SGT
|
|
|
Paltalk, Inc. Reports Slight Increase in Revenue and 33% Reduction in Net Loss for First Quarter 2024
May 9, 2024 20:39 JST
|
|
|
ソニー独自のマイクロサージャリー支援ロボットを開発
May 9, 2024 18:00: JST
|
|
|
Honda、インドでの電動化の加速に向けた研究開発拠点をベンガルールに開設
May 9, 2024 13:50: JST
|
|
|
LEXUS、「LM」に6座仕様車を追加設定
May 9, 2024 13:45: JST
|
|
|
富士通、がんのタイプ分けなどのゲノム医療分野の課題を世界最高精度で解く、説明可能なAI技術を開発
May 9, 2024 13:30: JST
|
|
|
Honda Opens New R&D Facility in Bengaluru to Accelerate Electrification in India
May 9, 2024 14:13 JST
|
|
|
Malaysian Retail Sector Sees a 173% Growth in Hiring: foundit Insights Tracker
May 9, 2024 12:00 HKT/SGT
|
|
|
Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning
May 9, 2024 10:41 JST
|
|
|
Solar & Storage Live Philippines Leading Sustainability And Innovation In The Philippines Energy Sector
May 9, 2024 08:19 HKT/SGT
|
|
|
Saakuru and Blockpass Partner for Compliance in the Best Economic Opportunities Web3 Offers
May 9, 2024 08:00 HKT/SGT
|
|
|
Avance Clinical, 한국에서 새로운 임상 운영으로 APAC 지역으로 더 확장
May 9, 2024 08:00 HKT/SGT
|
|
|
SMC Announces LOI to Acquire Chaintrade LTD.
May 9, 2024 07:59 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|